Cargando…

Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()

Accurately identifying the patients that have mild cognitive impairment (MCI) who will go on to develop Alzheimer's disease (AD) will become essential as new treatments will require identification of AD patients at earlier stages in the disease process. Most previous work in this area has centr...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Jonathan, Modat, Marc, Cardoso, Manuel J., Mendelson, Alex, Cash, Dave, Ourselin, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777690/
https://www.ncbi.nlm.nih.gov/pubmed/24179825
http://dx.doi.org/10.1016/j.nicl.2013.05.004
_version_ 1782285002699964416
author Young, Jonathan
Modat, Marc
Cardoso, Manuel J.
Mendelson, Alex
Cash, Dave
Ourselin, Sebastien
author_facet Young, Jonathan
Modat, Marc
Cardoso, Manuel J.
Mendelson, Alex
Cash, Dave
Ourselin, Sebastien
author_sort Young, Jonathan
collection PubMed
description Accurately identifying the patients that have mild cognitive impairment (MCI) who will go on to develop Alzheimer's disease (AD) will become essential as new treatments will require identification of AD patients at earlier stages in the disease process. Most previous work in this area has centred around the same automated techniques used to diagnose AD patients from healthy controls, by coupling high dimensional brain image data or other relevant biomarker data to modern machine learning techniques. Such studies can now distinguish between AD patients and controls as accurately as an experienced clinician. Models trained on patients with AD and control subjects can also distinguish between MCI patients that will convert to AD within a given timeframe (MCI-c) and those that remain stable (MCI-s), although differences between these groups are smaller and thus, the corresponding accuracy is lower. The most common type of classifier used in these studies is the support vector machine, which gives categorical class decisions. In this paper, we introduce Gaussian process (GP) classification to the problem. This fully Bayesian method produces naturally probabilistic predictions, which we show correlate well with the actual chances of converting to AD within 3 years in a population of 96 MCI-s and 47 MCI-c subjects. Furthermore, we show that GPs can integrate multimodal data (in this study volumetric MRI, FDG-PET, cerebrospinal fluid, and APOE genotype with the classification process through the use of a mixed kernel). The GP approach aids combination of different data sources by learning parameters automatically from training data via type-II maximum likelihood, which we compare to a more conventional method based on cross validation and an SVM classifier. When the resulting probabilities from the GP are dichotomised to produce a binary classification, the results for predicting MCI conversion based on the combination of all three types of data show a balanced accuracy of 74%. This is a substantially higher accuracy than could be obtained using any individual modality or using a multikernel SVM, and is competitive with the highest accuracy yet achieved for predicting conversion within three years on the widely used ADNI dataset.
format Online
Article
Text
id pubmed-3777690
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-37776902013-10-31 Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment() Young, Jonathan Modat, Marc Cardoso, Manuel J. Mendelson, Alex Cash, Dave Ourselin, Sebastien Neuroimage Clin Article Accurately identifying the patients that have mild cognitive impairment (MCI) who will go on to develop Alzheimer's disease (AD) will become essential as new treatments will require identification of AD patients at earlier stages in the disease process. Most previous work in this area has centred around the same automated techniques used to diagnose AD patients from healthy controls, by coupling high dimensional brain image data or other relevant biomarker data to modern machine learning techniques. Such studies can now distinguish between AD patients and controls as accurately as an experienced clinician. Models trained on patients with AD and control subjects can also distinguish between MCI patients that will convert to AD within a given timeframe (MCI-c) and those that remain stable (MCI-s), although differences between these groups are smaller and thus, the corresponding accuracy is lower. The most common type of classifier used in these studies is the support vector machine, which gives categorical class decisions. In this paper, we introduce Gaussian process (GP) classification to the problem. This fully Bayesian method produces naturally probabilistic predictions, which we show correlate well with the actual chances of converting to AD within 3 years in a population of 96 MCI-s and 47 MCI-c subjects. Furthermore, we show that GPs can integrate multimodal data (in this study volumetric MRI, FDG-PET, cerebrospinal fluid, and APOE genotype with the classification process through the use of a mixed kernel). The GP approach aids combination of different data sources by learning parameters automatically from training data via type-II maximum likelihood, which we compare to a more conventional method based on cross validation and an SVM classifier. When the resulting probabilities from the GP are dichotomised to produce a binary classification, the results for predicting MCI conversion based on the combination of all three types of data show a balanced accuracy of 74%. This is a substantially higher accuracy than could be obtained using any individual modality or using a multikernel SVM, and is competitive with the highest accuracy yet achieved for predicting conversion within three years on the widely used ADNI dataset. Elsevier 2013-05-19 /pmc/articles/PMC3777690/ /pubmed/24179825 http://dx.doi.org/10.1016/j.nicl.2013.05.004 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Young, Jonathan
Modat, Marc
Cardoso, Manuel J.
Mendelson, Alex
Cash, Dave
Ourselin, Sebastien
Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
title Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
title_full Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
title_fullStr Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
title_full_unstemmed Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
title_short Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment()
title_sort accurate multimodal probabilistic prediction of conversion to alzheimer's disease in patients with mild cognitive impairment()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777690/
https://www.ncbi.nlm.nih.gov/pubmed/24179825
http://dx.doi.org/10.1016/j.nicl.2013.05.004
work_keys_str_mv AT youngjonathan accuratemultimodalprobabilisticpredictionofconversiontoalzheimersdiseaseinpatientswithmildcognitiveimpairment
AT modatmarc accuratemultimodalprobabilisticpredictionofconversiontoalzheimersdiseaseinpatientswithmildcognitiveimpairment
AT cardosomanuelj accuratemultimodalprobabilisticpredictionofconversiontoalzheimersdiseaseinpatientswithmildcognitiveimpairment
AT mendelsonalex accuratemultimodalprobabilisticpredictionofconversiontoalzheimersdiseaseinpatientswithmildcognitiveimpairment
AT cashdave accuratemultimodalprobabilisticpredictionofconversiontoalzheimersdiseaseinpatientswithmildcognitiveimpairment
AT ourselinsebastien accuratemultimodalprobabilisticpredictionofconversiontoalzheimersdiseaseinpatientswithmildcognitiveimpairment
AT accuratemultimodalprobabilisticpredictionofconversiontoalzheimersdiseaseinpatientswithmildcognitiveimpairment